Effect and Prognosis Factors of Combining Laparoscopic Radical Resection of Colon Adenocarcinoma with Docetaxel Therapy in Treating Middle and Advanced Colon Adenocarcinoma

Table 1

RECIST criteria.

Efficacy	Criteria
CR	Disappearance of all lesions for at least 4 weeks
PR	Lesion with dual measurable diameters, >50% decrease in the sum of the longest diameters (SLD) of the targeted lesions for at least 4 weeks
SD	Lesion with dual measurable diameters, neither sufficient decrease to qualify for PR nor sufficient increase to qualify for PD, for at least 4 weeks
PD	>25% increase of one or more lesions, or appearance of new lesions